Kemnay Advisory Services »

Bridgebio Pharma shares owned by Kemnay Advisory Services

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Kemnay Advisory Services from 13F filings

Historical chart of Kemnay Advisory Services investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Kemnay Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Kemnay Advisory Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $100k 1.4k 74.26
2025-12-31 $41k 539 76.49

More positions owned by Kemnay Advisory Services

Vornado Rlty Tr Sh Ben Int (VNO)
Ishares Msci Japan Etf (EWJ)
Coinbase Global Com Cl A (COIN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ishares Tr Msci India Etf (INDA)
Amazon (AMZN)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Meta Platforms Cl A (META)

View all positions for Kemnay Advisory Services

Top funds holding Bridgebio Pharma

BlackRock
Kohlberg Kravis Roberts & Co
Henderson Group
Viking Global Investors
Farallon Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
UBS Group
Aisling Capital Management
Jane Street
State Street Corporation
Geode Capital Management
Invesco
T. Rowe Price Associates
Susquehanna International

View all funds holding Bridgebio Pharma